Liver transplant recipients gain up to 17 life-years from living donors vs. donor waitlist

August 30, 2022

A case-control study in JAMA Surgery revealed that patients with end-stage liver disease had a 34% reduction in mortality after living-donor liver transplantation compared with patients who remained on a wait list for a deceased donor.Researchers wrote that the survival benefit of living-donor liver transplantation (LDLT), especially in patients with low MELD incorporating sodium levels (MELD-Na) scores, is “remarkable,” as previously published studies with deceased donors noted that such benefits occurred in patients with scores of 15 or higher.“This study’s findingsRead More

Categories: News

Related Articles

CRC patients with unresectable liver metastases may benefit from living-donor LT

Living-donor liver transplantation may be a viable option for patients with unresectable, liver-confined colorectal cancer liver metastases, according to a study published in JAMA Surgery.“This…

Expanding split liver transplants critical to stop children ‘dying on the waitlist’

Expanding access to split liver transplants and adopting a “split first” policy on donor livers will significantly reduce mortality on the pediatric waitlist, noted a…

MELD 3.0 corrects disparity in access to liver transplant for women

An updated MELD 3.0 amends existing sex-based disparities in access to liver transplantation among women, according to a presenter at the American Transplant Congress 2022.“Before…

Delayed vs. early surgery linked to shorter survival in advanced esophageal cancer

Early surgery prolonged survival compared with delayed surgery among patients with stage II to stage III esophageal cancer, according to study results published in Journal…

August 16, 2022

Let’s Talk About Physician Burnout

Physician Burnout has become a serious topic of discussion in the healthcare field lately. With such a large array of factors affecting the well-being…

Justin Bouck June 5, 2018